- Trials with a EudraCT protocol (140)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
140 result(s) found for: Midazolam.
Displaying page 4 of 7.
| EudraCT Number: 2018-002542-37 | Sponsor Protocol Number: P170409J | Start Date*: 2018-11-13 |
| Sponsor Name:Assistance Publique Hôpitaux de Paris | ||
| Full Title: NA | ||
| Medical condition: acute gout crisis | ||
| Disease: | ||
| Population Age: | Gender: | |
| Trial protocol: FR (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000059-29 | Sponsor Protocol Number: PI2016_843_0001 | Start Date*: 2016-04-25 |
| Sponsor Name:CHU AMIENS-PICARDIE | ||
| Full Title: | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FR (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003961-49 | Sponsor Protocol Number: P261-301 | Start Date*: 2015-03-03 | |||||||||||
| Sponsor Name:Upsher-Smith Laboratories, Inc. | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo Controlled Trial Examining the Safety and Efficacy of Midazolam Intranasal Spray (USL261) for the Treatment of Intermittent Bouts of Increased Seizure Activity i... | |||||||||||||
| Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) CZ (Completed) IT (Completed) DE (Completed) ES (Completed) AT (Completed) LT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-001318-32 | Sponsor Protocol Number: P261-401 | Start Date*: 2011-11-17 | |||||||||||
| Sponsor Name:Upsher-Smith Laboratories, Inc. | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects with Seizure Clusters ARTEMIS-1: Acute Rescu... | |||||||||||||
| Medical condition: epilepsy | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-004745-70 | Sponsor Protocol Number: 55438 | Start Date*: 2018-11-06 |
| Sponsor Name:Academic Medical Center (AMC) | ||
| Full Title: Efficacy of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial (Ketamine Trial Amsterdam, KETA) | ||
| Medical condition: Acute suicidality, which is a rapid increase in suicidal ideation or behaviour from the patient's 'baseline' in the last 24 hours. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-004415-22 | Sponsor Protocol Number: 632-31 | Start Date*: 2007-02-19 | |||||||||||
| Sponsor Name:Karolinska University Hospital | |||||||||||||
| Full Title: Utvärdering av två oloika strategier att smärtbehandla patienter som genomgår ablationsbehandling mot hjärtrytmrubbningar i hjärtat | |||||||||||||
| Medical condition: Patients undergoing catheter ablation due to arrhythmias. | |||||||||||||
|
|||||||||||||
| Population Age: | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-001568-35 | Sponsor Protocol Number: RGHT000559 | Start Date*: 2008-06-24 |
| Sponsor Name:BELFAST HEALTH & SOCIAL CARE TRUST | ||
| Full Title: Comparison of fascia iliac compartment block with conventional sedation to facilitate the positioning of patients with fractured neck of femur for spinal anaesthesia and the effect of nerve blockad... | ||
| Medical condition: Investigation of the use a Fascia Iliaca nerve blockade for both positioning for spinal anaesthesia and postoperative analgesia in patients undergoing operative repair of fractured neck of femur. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-018992-16 | Sponsor Protocol Number: PI10 - Pr. Dupont | Start Date*: 2010-12-30 | |||||||||||
| Sponsor Name:Centre hospitalier universitaire d'Amiens | |||||||||||||
| Full Title: Evaluation pharmacocinétique de MDZ028 après administration unique d'une forme orale nouvelle, lors de la prémédication anesthésique chez l'enfant. | |||||||||||||
| Medical condition: prémédication anesthésique | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-005274-38 | Sponsor Protocol Number: BRONSE | Start Date*: 2016-03-10 |
| Sponsor Name:Region Östergötland | ||
| Full Title: Patient-controlled sedation with propofol versus combined sedation during bronchoscopy – a randomized controlled trial | ||
| Medical condition: Diagnostic bronchoscopy for referred outpatients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-004044-28 | Sponsor Protocol Number: AKF-396 | Start Date*: 2020-12-18 | |||||||||||
| Sponsor Name:University of Southern Denmark | |||||||||||||
| Full Title: Flucloxacillin as an inducer of CYP-enzymes | |||||||||||||
| Medical condition: Healthy volunteers. (Flucloxacillin is used against infections caused by beta-lactamase-producing organisms) Testing for drug-drug interactions caused by flucloxacillin | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-004158-33 | Sponsor Protocol Number: CYP3A4/5+PGPinRenalTx | Start Date*: 2008-09-17 | |||||||||||
| Sponsor Name:Department of Nephrology and Renal Transplantation, KU Leuven | |||||||||||||
| Full Title: CYP3A4/5 and PGP activity in renal transplantation. A study assessing in vivo hepatic and intestinal CYP3A4/5 and PGP activity in kidney transplant recipients and its relationship with genetic and... | |||||||||||||
| Medical condition: Effect of genetic (single nucleotide polymorphisms of genes encoding drug metabolising enzymes and drug transporters) and non-genetic factors (e.g. age, time after transplantation, concommitant med... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-004069-16 | Sponsor Protocol Number: CYP3A4/5RenalTx | Start Date*: 2007-10-19 | |||||||||||
| Sponsor Name:Department of Nephrology and Renal Transplantation, KU Leuven | |||||||||||||
| Full Title: Hepatic and intestinal CYP3A4/5 activity in renal transplantation. A study assessing in vivo hepatic and intestinal CYP3A4/5 activity at different time-points and in different clinical settings af... | |||||||||||||
| Medical condition: Effect of genetic (single nucleotide polymorphisms of genes encoding drug metabolising enzymes and drug transporters) and non-genetic factors (e.g. age, time after transplantation, concommitant me... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-002905-24 | Sponsor Protocol Number: 74304 | Start Date*: 2021-07-07 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Efficacy and feasibility of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial (Ketamine Trial for Acute suicidalty, KETA) | ||
| Medical condition: Acute suicidality, which is a rapid increase in suicidal ideation or behaviour from the patient's 'baseline' in the last 24 hours. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004422-42 | Sponsor Protocol Number: ESKETINSUI2002 | Start Date*: 2017-10-02 | ||||||||||||||||||||||||||
| Sponsor Name:Janssen-Cilag International NV | ||||||||||||||||||||||||||||
| Full Title: A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensiv... | ||||||||||||||||||||||||||||
| Medical condition: Major Depressive Disorder with Imminent Risk of Suicide | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: HU (Completed) ES (Restarted) BE (Completed) PL (Completed) IT (Completed) BG (Completed) FR (Completed) Outside EU/EEA | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2004-002966-39 | Sponsor Protocol Number: STH13844 | Start Date*: 2006-12-22 |
| Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
| Full Title: A Double-blind randomised controlled trial to compare buscopan versus placebo as an adjunct to colonoscopy | ||
| Medical condition: pathology of the large bowel as detected by colonoscopy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-006826-33 | Sponsor Protocol Number: CHU-P 2008-07 | Start Date*: 2009-03-20 |
| Sponsor Name:CHU d'Angers | ||
| Full Title: Effet d’une prémédication sur la douleur, en IRM fonctionnelle, chez des volontaires sains. | ||
| Medical condition: volontaire sain en situation de prémédication identique à celle administrée avant une intervention chirurgicale. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-014741-89 | Sponsor Protocol Number: 0916202 | Start Date*: 2009-10-20 |
| Sponsor Name:Centre Hospitalier de Toulouse | ||
| Full Title: Recherche de la DE90 d'un bolus de sufentanil pour l'analgésie des soins douloureux de nursing des malades intubés de réanimation | ||
| Medical condition: patients intubés en réanimation sous ventilation mécanique | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-015771-27 | Sponsor Protocol Number: V3 | Start Date*: 2010-01-21 |
| Sponsor Name:Medizinische Universität Wien, Univ.Klinik für Notfallmedizin | ||
| Full Title: Requirement of Skeletal Muscle Paralysis in Hypothermic Patients after Cardiac Arrest. A pilot study | ||
| Medical condition: skeletal muscle paralysis in hypothermic patients after cardiac arrest | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004836-61 | Sponsor Protocol Number: Dexmed-2006-PICU | Start Date*: 2006-11-08 |
| Sponsor Name:Royal Hospital for Sick Children, Glasgow | ||
| Full Title: Dexmedetomidine as a sedative in paediatric intensive care. | ||
| Medical condition: Children who require sedation and analgesia whilst receiving ventilatory support in the paediatric intensive care unit. | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004455-36 | Sponsor Protocol Number: NP28673 | Start Date*: 2013-04-11 | |||||||||||
| Sponsor Name:F.Hoffmann-La Roche Ltd | |||||||||||||
| Full Title: AN OPEN-LABEL, NON-RANDOMIZED, MULTICENTER PHASE I/II TRIAL OF RO5424802 GIVEN ORALLY TO NON - SMALL CELL LUNG CANCER PATIENTS WHO HAVE ALK MUTATION AND FAILED CRIZOTINIB TREATMENT | |||||||||||||
| Medical condition: ALK-mutated Non-small cell lung cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) GB (Completed) DE (Completed) IT (Completed) ES (Completed) NL (Completed) BE (Completed) FR (Completed) DK (Completed) LU (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.